ArticleCureus2025
Metastatic Lung Adenocarcinoma in a Lifetime Nonsmoker With an Atypical Radiological and Clinical Presentation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer remains the leading cause of cancer-related deaths globally. While smoking-related lung cancers still account for most cases and cause approximately 100,000 deaths annually in the USA, smoking rates have been declining for decades. Lung cancer in never-smokers (LCINS), which tends to affect women and Asian populations, is now the fifth most common cause of cancer-related deaths worldwide. In 2023, over 20,000 lung cancer deaths in the USA were projected to occur in never-smokers, making LCINS the eighth leading cause of cancer-related mortality in the country. As the number of LCINS cases rises, it becomes increasingly important to explore the unique causes and characteristics of the disease, which calls for tailored diagnostic approaches and personalized treatment plans. Lung adenocarcinoma (LUAD) can present with atypical imaging features that often resemble benign conditions, including pneumonia, lung abscesses, post-infectious scarring, atelectasis, mediastinal masses, emphysema, and granulomatous disease. This variability in presentation can hinder accurate diagnosis and potentially delay timely treatment. While lung cancer is uncommon in younger individuals, with only 5.6% of new cases occurring in those under 54 years old, clinicians should maintain a high index of suspicion, as early detection is essential, and atypical cases can be easily missed. Here, we present a complex case involving an unusual radiologic manifestation of a lung mass, in which tuberculosis was initially considered the primary differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.